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Abstract— Asthma affects a large number of people in the 
world and it is the most common chronic illness of the lung among 
children. Monitoring and assessing the severity of a child’s asthma 
at home has proven difficult and costly in many low resource 
settings, like Kenya. This is due to lack of easy to use and cost 
effective in-home monitoring tools for children suffering from 
asthma. 
In this work, we present a user-friendly wearable device that 
allows in-home remote monitoring of asthmatic child and real-time 
determination of degree of asthma severity. The device captures 
simultaneous measurements of heart rate and oxygen saturation 
using a pulse oximeter sensor. These readings are then analyzed 
using clinical algorithm for asthma management, and the resulting 
severity level sent to both the parent of the child and the assigned 
clinician. The device was developed using Arduino Uno 
microcontroller, pulse oximeter sensor and Global System for 
Mobile Communication (GSM) module. 
Keywords— Asthma, clinical guidelines, Arduino uno 
microcontroller, pulse oximeter sensor, GSM, Internet of   Things. 
I.  INTRODUCTION 
Asthma is the most common chronic illness of the lung, 
characterized by respiratory symptoms such as shortness of 
breath, wheeze, chest tightness and cough, with children under-
fives in particular, at the greatest risk [1]. Globally, it is 
estimated to affect over 300 million people [2]. Numerous 
reports indicate that the prevalence of asthma may be 
increasing in most parts of the world including low income 
countries (LIC) [3, 4]. The International Study of Asthma and 
Allergies (ISAAC) reported that asthma prevalence among 
children was increasing in Africa and has contributed most to 
the burden of disease through its effects on quality of life [5]. 
In most health care settings around the world, asthma 
severity is often under-estimated and preventative treatments 
either under-prescribed or overprescribed [6, 7]; this may result 
in poor asthma control and lead to an increase in degree of 
severity, thus a deterioration in patient’s health. On the other 
hand, inappropriate treatment is a cause of a substantial cases 
of hospital readmissions. 
The public health focus of asthma relies on early case 
detection and placement of the affected individuals on 
appropriate and largely lifelong treatment with proper 
monitoring in order to control the disease. In most LIC such as 
Kenya, there are no public supported asthma-care programmes 
designed to optimize care for patients with asthma which 
greatly compounds the diagnosis, severity classifications and 
treatment problems. Under these circumstances, the 
development of standardized, well defined home-tailored 
interventions together with sound professional practice is 
crucial. This has seen management of asthmatic patients [8, 9] 
as concerned bodies and many countries developing clinical 
guidelines in order to improve treatment and  
In 2013,  the Ministry of Health (MoH) in collaboration 
with the Kenya Medical Research Institute (KEMRI)-
Wellcome Trust Research Programme, the Kenya Paediatric 
Association (KPA) and the SIRCLE saw the development and 
routine update of a basic paediatric protocol that constitutes 
clinical guidelines (algorithms) for under five years 
management [9]. These guidelines focus on various illnesses, 
including classification of asthma severity, criteria for 
admission, treatment and inpatient management of the major 
causes of childhood mortality and related conditions. 
 
Monitoring and assessing the severity of a child’s asthma at 
home has proven difficult and costly in many low resource 
settings, like Kenya. Parents finds it difficult to determine the 
severity of a child’s asthma state in-home, and they often face 
challenges in deciding whether the child requires 
administration of medicines, a visit to the clinician or 
emergency medical care. Thus, they are unable to prevent 
unexpected critical episodes, such as recurrent readmissions to 
emergency rooms, unnecessary acute attacks and sometimes 
loss of life. It is a general premise that information technology 
(IT) can play a crucial role in addressing these challenges in 
order to ensure self-management of conditions such as asthma 
possible at home. 
With the recent popularity of smart health monitoring 
devices in medical sphere and m-health, real-time remote 
monitoring tools can help monitor asthmatic patient’s health 
state, classify degree of asthma severity and alert clinicians on 
the health state of the patient. 
Here, we present a user-friendly wearable device that allows 
in-home remote monitoring and reduces the difficulty of 
assessing the degree of asthma severity. The device captures 
simultaneous measurements of heart rate and oxygen 
saturation using a pulse oximeter sensor. These readings are 
then analyzed using clinical algorithm for asthma 
management, and the resulting severity level sent to both the 
parent of the child and the assigned clinician in form of a text. 
II. LITERATURE REVIEW 
A. Asthma in Kenya 
Asthma is a non-communicable disease characterized by 
recurrent attacks of breathlessness and wheezing, with varying 
severity in individuals, and may occur unexpectedly. In 
Kenya, a number of epidemiological studies that have shown 
that its prevalence is at 10% [8], and it is on the rise. The 
illness appears to be more prevalent in densely populated 
regions such as urban areas compared to sparsely-populated 
rural areas. The major drivers of the burden of asthma in 
Kenya, as in other parts of the world, are largely unknown 
even though it is appreciated that complex and poorly 
understood genetic factors interact with environmental factors 
to lead to the manifestation of the disease.  
Asthma patients face a number of challenges. Despite under-
estimation of asthma severity levels, especially in children, 
poor prescription of drugs which could be either under 
prescribed or over prescribed, usually put their lives at risk 
[6]. In addition to this, there are no public supported asthma-
care programmes designed to optimize care which greatly 
compounds the diagnosis, severity classifications and 
treatment problems. 
 
 Asthma being a chronic disease, implies long term health 
consequences for the sick, greater health resource utilization 
and a heavy economic burden to the country as a whole. 
Although a large proportion of these diseases are preventable 
through adoption of appropriate healthy lifestyles, there are no 
proven ways to prevent the disease.  
Asthma has important individual health consequences. 
Uncontrolled asthma results in recurrent or persistent 
symptoms that impair quality of life, reduce self-esteem, 
reduce social interaction, increase psychosocial trauma and 
occasionally lead to fatal outcomes. The economic costs of 
uncontrolled asthma may be enormous and include direct costs 
from health resource utilization (medical consultations, drug 
and hospitalization costs), indirect costs from work 
absenteeism or premature deaths and intangible costs of 
persistent illness. 
Therefore, in order to prevent the patients from frequent 
readmissions, ill-health and save them from unnecessary loss 
of life, an individual patient should be diagnosed and severity 
level detected early enough, be placed on appropriate 
medication and lifelong treatment. It has been documented 
that patients suffering any disease who are managed according 
to set guidelines fair better than those managed otherwise [10, 
11, 12]. 
 
B. Classification of Asthma 
Poor classification of asthma severity by clinicians while 
attending to asthmatic patients have been demonstrated in a 
number of previous studies [13], and this have detrimental 
effects to the health of an individual patient [14]. In order to 
administer an appropriate treatment to an asthmatic patient, 
the correct severity group for the patient needs to be 
established beforehand. 
According to the Basic Paediatric Protocols for children under 
five years of age in Kenya, acute severe asthma has been 
classified by the Ministry of Health into severe, mild or 
moderate asthma [9]. Severe asthma is characterized by the 
presence of central cyanosis, inability to talk, drink or 
breastfeed, Alertness Verbal response Pain responsiveness and 
Unresponsiveness (AVPU) of scale at either V, P or U, with 
measurements of oxygen saturation < 90% and pulse rate less 
than 200 bpm for children under three years and pulse rate 
greater than 180 bpm for those between four and five years. 
On the other hand, mild or moderate asthma comprises all 
asthmatic patients with presence of wheeze, plus any of the 
following: lower chest wall indrawing or fast breathing (RR ≥ 
50 for aged 2-11 months and RR ≥ 40 for aged 12-59 months). 
 
C. Management of Asthma 
With the escalating number of asthma cases witnessed 
globally over the decades [15], the disease need proper 
management plan. As a chronic illness with no cure, the nature 
of asthma requires proper diagnosis, appropriate severity 
classification, correct treatment and continuous monitoring by 
relevant clinicians [1].  
Patients on treatment for asthma should be reviewed regularly 
and their treatment adjusted as may be necessary. With 
appropriate treatment most patients with asthma can gain and 
maintain asthma control and thus lead normal productive lives. 
The clinician should assess the severity of asthma or the level 
of control for diagnosed asthma on treatment, initiate 
treatment at the appropriate treatment step based on the 
asthma severity or level of control and arrange for a home-
based monitoring process to assess response to treatment and 
patient’s progress. The main aim of day to day management of 
asthma helps prevent frequent readmissions, ill-health, 
unnecessary attacks and to bring back patients to productive 
lives. This has seen national and international concerned 
bodies developing clinical guidelines in order to control the 
management of asthmatic patients [1, 2, 8]. 
  
D. Clinical Guidelines for Asthma Management 
Clinical guidelines are part of better clinical practice. In any 
health care setting, daily bedside clinical decisions and rules 
of operation at these facilities are being influenced by 
guidelines. According to the Institute of Medicine, clinical 
guidelines are “systematically developed statements to assist 
practitioner and patient decisions about appropriate health care 
for specific clinical circumstances [16]. Their benefits extend 
to offering precise instructions on which diagnostic or tests to 
be done, how to administer or prescribe medications, how long 
patients should stay in hospital, or other details of clinical 
practice. Clinicians and policy makers see guidelines as a tool 
for ensuring consistent code of practice and for closing the gap 
between what clinicians do and what scientific evidence 
supports. 
Kenya is making efforts to improve the health of its 
population through strengthening of the primary health care 
system, and thus there has been efforts to manage asthma. In 
2006, the Kenya Association for the Prevention of 
Tuberculosis and Lung Disease (KAPTLD) in partnership 
with the Ministry of Health and the pharmaceutical industry 
developed a ‘consensus statement’ on the management of 
asthma in Kenya. This was later renamed the ‘Kenya national 
asthma guidelines’ to reflect the purpose for which it has been 
developed. The primary purpose of this new document is to 
provide clinicians, researchers, policy makers, health 
programme developers and managers with a road map to guide 
the care of individual patients with asthma in Kenya [8]. 
Further work in 2013 by the Ministry of Health (MoH) in 
collaboration with the Kenya Medical Research Institute 
(KEMRI)-Wellcome Trust Research Programme, the Kenya 
Paediatric Association (KPA) and the SIRCLE saw the 
development and routine update of a basic paediatric protocol 
as shown in figure 2:1, that constitutes clinical guidelines 
(algorithms) for under five years management [9]. These 
guidelines focus on the classification of various illnesses’ 
severity, among them asthma, criteria for admission, treatment 
and inpatient management of the major causes of childhood 
mortality. 
The guidelines represent a major milestone in the development 
of asthma care services in Kenya. It is hoped that these 
guidelines will be widely disseminated and used by all cadres 
of health care providers in Kenya to promote asthma care 
practices that ensure the best possible outcomes for 
individuals who suffer this disease.  
 
Figure 1:1: National Asthma Guidelines (Adopted from Basic 
Paediatric Protocol of Kenya 2016) 
 
E. Existing Tools for Monitoring Asthma Management 
There are a number of technologies that have been applied in 
health care to help monitor how asthma is managed both 
during hospital stay and at home. The aim of these tools is to 
ensure that asthmatic patients are treated as per the national 
clinical guidelines, and that they are saved from any danger 
that may arise as a result of poor management. 
 
i. Related Applications 
Persons suffering from chronic illnesses such as asthma 
should receive support to help them manage their illnesses as 
effectively as possible. A number of IoT-based healthcare 
novel technologies have been applied in health sector in an 
attempt to monitor and manage chronic illnesses [17]. Asthma 
is a growing problem among nations, and clinical guidelines 
have stressed the importance of at-home monitoring in the 
establishment and maintenance of asthma control, defined as 
the degree to which the manifestations of asthma are 
minimized by therapy [18]. 
 Examples include Identi-wheez, a portable and low cost 
device that aims to reduce the difficulties of asthma diagnosis, 
[19] have been used as a device for in-home diagnosis of 
asthma. It is composed of a novel measurement hardware and 
diagnosis algorithm. The device acquires simultaneous 
measurements from multiple stethoscopes. The recordings are 
then sent to a specialist who uses assistive diagnosis 
algorithms that enable auscultation (listening to lung sounds 
with a stethoscope) at any location in the lungs volume by 
sound refocusing. The specialist is also presented with a sound 
“heat map” which shows the location of sound sources in the 
lungs. 
In order to improve the condition of asthma patient, efforts 
have also been made to develop systems that monitor 
environmental conditions, such as air quality, and trigger 
warnings and alerts. Environment crowd sensing for asthma 
management has been developed for monitoring the 
environment, especially the air quality parameters relevant for 
asthma patients [32]. Recent work from Vasilateanu had 
suggested a mobile application- AsthMate, to be used by 
asthma patients to monitor their health by doctors and by 
institutions. The device is able to detect high risk areas for 
asthma suffers based on quality of air measurements and 
incidence of the use of short—term relief medication. A work 
Towards Real-time Monitoring and Detection of asthma 
symptoms on resource-constraint mobile device, [20] a 
smartphone application that could detect and quantitatively 
index early signs of asthma attack triggered by exercise. Here, 
the embedded microphone in the mobile phone records the 
user’s breath sound while motion sensors- accelerometer, 
gyroscope and digital compass provide measurements on the 
level or intensity of activity and posture changes. 
Though significant advances have been made in this field, 
there continues to be a lack of an ideal solution that would 
facilitate in-home asthma diagnosis. Table 1 presents a 
comparison of existing solutions and demonstrates where 





Table 1: Relevance of asthma severity monitoring tool 
 
 
F. Gaps in Exististing Tools for Monitoring Asthma 
Severity 
There exists a gap in an attempt to manage asthmatic patients 
from home. The existing tools such as peak flow meter or 
spirometer are only found in hospitals, and are costly and 
difficult to use due to complications and contraindications. In 
addition, reliable results cannot be obtained as the patient 
instructions are complicated and the test causes chest pain. 
Moreover, children below the age of 6 years old are generally 
unable to perform an adequate test.  
Currently, once diagnosed and treatment administered, the 
asthmatic children are discharged home and put under long-
term drugs and inhalers. Rarely is their conditions monitored 
by clinicians at home during the treatment period. This could 
be attributed to lack of proper device to monitor and assess 
asthma severity level. Recent advances in medical sensors and 
smart health monitoring devices have greatly enabled remote 
health monitoring to support early diagnosis, detection of early 
signs of asthma attack as triggered by exercise and 
identification of conducive environment for asthmatic patients. 
However, the use of these tools as a home-based monitoring 
process to routinely assess patient’s response to treatment and 
progress is yet to be exploited in low resource settings, like 
Kenya. With the knowledge of patient’s asthma severity levels 
at hand at intervals of time, the clinician is able to review 
regularly and adjust patient’s treatment as may be necessary. 
With appropriate treatment, most patients with asthma can 
gain and maintain asthma control and thus lead normal 
productive lives. 
 This project aimed to improve on the home-based asthma 
diagnostic tool by [19], and to develop further a simple to use 
remote monitoring tool based on pulse oximeter for asthmatic 
patients that will allow instant determination of severity level 
of asthma and alert the patient as well as the caregiver or 
clinicians about the patient status. This provides the caregivers 
and clinicians with real time information for better informed 
clinical decisions regarding the most appropriate treatment and 
care for the asthmatic child. 
G. Device Description 
Figure 1:2 presents the system architecture of the home-based 
asthma severity monitoring device. This is a wearable and 
portable device that consists of a novel measurement hardware 
and analytical algorithm. The analytical algorithm is 
formulated from Basic Paediatric protocols’ clinical guidelines 
for asthma that are used to classify severity of asthma in 
Kenya. On the other hand, the hardware constitutes Arduino 
Uno microcontroller that interconnects with pulse oximeter 
sensor and the Global System for Mobile Communication 












Figure 1:3: Home-based patient monitoring device 
 
III. IMPLIMENATION AND TESTING    
A. Working Principle of the home-based patient 
monitoring device 
Arduino is used for controlling the whole process. With the 
pulse oximeter sensor fitted on the finger at intervals of time, 
the device is able to capture simultaneously the oxygen 
saturation and heart rate measurements of the asthmatic 
patient. The recordings are then sent to the server for storage 
before being analyzed instantly based on the analytical 
algorithm to determine whether the patient has severe, mild or 
moderate asthma. This is then automatically sent to both the 
parent and the clinician via SMS using GSM module. The 
real-time feedback is used by the clinician to inform clinical 
decisions regarding the patient’s management. 
Based on the feedback, the clinician is able to review regularly 
and adjust treatment according to the evolution of the severity 
state of the child. Furthermore, an urgent visit to the clinic in 
case the alert from the system indicates a severe health state 
can be recommended. 
 
B. Testing 
Table 1-2 gives summary of a number of system testing, some 
including functionality, user experience and usability testing 
that was conducted during post-survey among respondents 
perceived to be the intended system users. 
Results gathered on the post-test analysis as indicated in Table 
1-2 gave a solid indication of the proposed solution meeting 
set objectives. The device was not only easy to use and highly 
acceptable to the users, but also good and tailored to the user 
needs. However, there is a substantial percentage of the 
respondents who suggested further improvement to the 
system. They advised the tool to be converted into a small, 





Table 1:1: System Architecture 
 
C. Implementation 
Upon further refinement of the device into a more lightweight 
and portable device with low power consumption, it will be 
implemented at health care facilities level under homecare 
asthma programme. Every asthmatic child who gets 
discharged home will be recruited into the programme.  The 
implementation strategy is to provide them with the device at 
the point of discharge and assign them to relevant healthcare 
professional (doctor). The device will be used to track and 
monitor them while at home and send real-time notification at 
specified instances to the assigned doctors. 
In order to capture and send real-time feedback to relevant 
caregiver, the asthmatic patient will be required to use the 
device in the morning, at lunch hour and in the evening before 
they go to sleep. This aims at ensuring that they get monitored 




IV. CONCLUSIONS AND FUTURE WORKS  
This model presents an elaborate method to facilitate full 
management of asthmatic child under five years at home. The 
home-based monitoring tool employs the use of pulse 
oximeter sensor to measure asthmatic patient’s oxygen 
saturation level and heart rate, which are among the key values 
used to determine severity level of asthma, among other 
factors. The data captured can also be visualize and the trend 
of patient severity followed over a given period of time. It 
would be worthwhile incorporating the use of other elements 
such as measuring inability to talk, inability to drink, central 
cyanosis and in drawing among asthmatic patients. 
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